Bioelectronics Corp
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that pro… Read more
Bioelectronics Corp (BIEL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2023: 0.004x
Based on the latest financial reports, Bioelectronics Corp (BIEL) has a cash flow conversion efficiency ratio of 0.004x as of March 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-64.03K) by net assets ($-15.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioelectronics Corp - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Bioelectronics Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioelectronics Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioelectronics Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Happy Town Holdings Inc
PINK:HPTN
|
-0.011x |
|
PMV Consumer Acquisition Corp
PINK:PMVCW
|
-0.048x |
|
First Class Metals PLC
LSE:FCM
|
-0.318x |
|
Unisource Corporate Corporation
PINK:USRC
|
0.000x |
|
Ultrack Systems Inc
PINK:MJLB
|
-0.006x |
|
Tarsin Mobile Inc
PINK:TMIX
|
N/A |
|
LEHMAN BROS HLDGS CAP TST V
PINK:LHHMQ
|
N/A |
|
Sterling Energy Resources Incorporated
PINK:SGER
|
-0.238x |
Annual Cash Flow Conversion Efficiency for Bioelectronics Corp (2013–2024)
The table below shows the annual cash flow conversion efficiency of Bioelectronics Corp from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-17.41 Million | $-164.15K | 0.009x | -53.76% |
| 2023-12-31 | $-16.48 Million | $-335.99K | 0.020x | -32.88% |
| 2022-12-31 | $-15.76 Million | $-478.60K | 0.030x | +43.37% |
| 2021-12-31 | $-15.12 Million | $-320.30K | 0.021x | -39.32% |
| 2020-12-31 | $-15.12 Million | $-528.04K | 0.035x | -28.89% |
| 2019-12-31 | $-14.57 Million | $-715.68K | 0.049x | -52.72% |
| 2018-12-31 | $-13.02 Million | $-1.35 Million | 0.104x | +27.70% |
| 2017-12-31 | $-10.68 Million | $-868.91K | 0.081x | -39.29% |
| 2016-12-31 | $-9.76 Million | $-1.31 Million | 0.134x | -31.02% |
| 2015-12-31 | $-8.86 Million | $-1.72 Million | 0.194x | +78463.18% |
| 2014-12-31 | $-8.15 Million | $-2.01K | 0.000x | +16.56% |
| 2013-12-31 | $-7.54 Million | $-1.60K | 0.000x | -- |